US Compounding Inc is recalling 1,931 syringes of LET Gel 4% (a combination of lidocaine, epinephrine, and tetracaine). This prescription topical anesthetic, used in medical settings, is being recalled because the labels are missing critical lot numbers and expiration dates, showing placeholder text like 'Lot# YYYDDYY@XX' and 'Beyond Use Date: MM/DD/YYY' instead. Without this information, healthcare providers cannot verify the product's shelf life or potency, which may lead to using a medication that is no longer effective or safe.
The absence of valid expiration and lot data means there is no assurance of the drug's stability or sterility over time. Using an expired or degraded anesthetic may result in inadequate pain management during medical procedures or unexpected side effects.
Drug recall baseline remedy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.